In one of the rare pharmaceutical fraud cases to hit a jury, an up-and-coming federal prosecutor squared off Tuesday against a hardened defense veteran. The government says former Intermune CEO W. Scott Harkonen made false statements about the company's star drug, but his defense lawyer sees jealous bureaucrats at work. Harkonen was indicted last year on two counts: wire fraud and felony misbranding of a drug.
Rare Pharmaceutical Fraud Trial Under Way in San Francisco
August 20, 2009